A new clinical trial to investigate the effectiveness of a novel cancer drug could drastically change how one of the most devastating global health challenges is managed in Kenya and beyond.
The trial which targets what researchers at the Aga Khan University Hospital in Nairobi are calling "the housekeeping gene", is using cutting-edge technology to study whether the drug could safely and effectively block the mutation of a gene into a cancer-causing variant.